Ascentage Pharma Group International (HKG:6855)
Hong Kong · Delayed Price · Currency is HKD 47.50
+1.12 (2.41%)
At close: Feb 13, 2026
HKG:6855 Market Cap
HKG:6855 has a market cap or net worth of 17.48 billion as of February 13, 2026. Its market cap has increased by 23.56% in one year.
Market Cap
17.48B
Enterprise Value
17.55B
Revenue
428.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
47.50
Market Cap Chart
Since October 28, 2019, HKG:6855's market cap has increased from 7.59B to 17.48B, an increase of 130.40%. That is a compound annual growth rate of 14.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 17.48B | -9.09% |
| Dec 31, 2025 | 19.23B | 36.66% |
| Dec 31, 2024 | 14.07B | 81.16% |
| Dec 29, 2023 | 7.77B | 17.12% |
| Dec 30, 2022 | 6.63B | -8.70% |
| Dec 31, 2021 | 7.26B | -14.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TransThera Sciences (Nanjing) | 27.43B |
| Genscript Biotech | 26.33B |
| InnoCare Pharma | 25.42B |
| PegBio | 24.66B |
| Ascletis Pharma | 17.42B |
| Zai Lab | 16.44B |
| Keymed Biosciences | 16.07B |
| Everest Medicines | 13.85B |